American tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics.
about
Cutaneous Leishmaniasis Vaccination: A Matter of QualityDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).IFNG +874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production.CD3+CD4negCD8neg (double negative) T lymphocytes and NKT cells as the main cytotoxic-related-CD107a+ cells in lesions of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.Montenegro skin test and age of skin lesion as predictors of treatment failure in cutaneous leishmaniasis.In vitro sensitivity of paired Leishmania (Viannia) braziliensis samples isolated before meglumine antimoniate treatment and after treatment failure or reactivation of cutaneous leishmaniasisApoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy.T-cell receptor Vβ repertoire of CD8+ T-lymphocyte subpopulations in cutaneous leishmaniasis patients from the state of Rio de Janeiro, Brazil.Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathologyLocal or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis.AIM2 inflammasome is associated with disease severity in tegumentary leishmaniasis caused by Leishmania (V.) braziliensis.Cytotoxic cell involvement in human cutaneous leishmaniasis: assessments in active disease, under therapy and after clinical cure.A novel case of human visceral leishmaniasis from the urban area of the city of Rio de Janeiro: autochthonous or imported from Spain ?In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.Assessment of a Leishmaniasis Reporting System in Tropical Bolivia Using the Capture-Recapture Method.Immunoperoxidase technique using an anti-Leishmania (L.) chagasi hyperimmune serum in the diagnosis of culture-confirmed American tegumentary leishmaniasis.Intralesional treatment with meglumine antimoniate in three patients with New World cutaneous leishmaniasis and large periarticular lesions with comorbidities.Influence of the Notch system in the therapeutic response of American tegumentary leishmaniasis.Parasitological and immunological follow-up of American tegumentary leishmaniasis patients.Micro-geographical variation among male populations of the sandfly, Lutzomyia (Nyssomyia) intermedia, from an endemic area of American cutaneous leishmaniasis in the state of Rio de Janeiro, Brazil.Risk factors for cutaneous leishmaniasis in the rainforest of Bolivia: a cross-sectional study.Development and validation of PCR-based assays for diagnosis of American cutaneous leishmaniasis and identification of the parasite species.Case Report: Mucosal Leishmaniasis Presenting with Nasal Septum Perforation after Almost Thirty YearsPhlebotominae sand flies in Paraguay: abundance distribution in the Southeastern region
P2860
Q26752521-1940BD4E-F156-4073-9B10-D2E8BA427CD4Q30275257-81CF71D7-E681-4E25-861B-A99A6AF0039DQ33282667-4647FC57-26AE-4A09-BCB6-EE62397FFC79Q33634962-E83BBC90-5AF5-4383-8857-0A029BF9B398Q33942376-94A8BB11-349C-4636-92E9-C1C12191CECDQ34229998-FCD9CCCC-C043-4915-B464-FE64370006E8Q35087276-15194C54-7665-48D0-A938-DACA4A3C666EQ35115431-C64EE372-09BB-43FA-974B-2CDEB509CFB6Q36059663-8BA507A4-EE0D-45A1-8A15-82D7F0667A5EQ36617322-605EB156-EFDC-47D3-B316-C43D0D15776BQ38136837-3460DB5A-52D8-40AA-9B77-CE81C532032EQ38842848-66B8750F-332F-4A75-A35B-75AF5543A1FEQ40772459-4A0C1F38-B45D-4DDB-BBDA-CA3623860BC5Q42347676-CBB39CE8-9012-4CA5-9103-E61AC2AA9500Q45080997-B3DC1FEC-1ACC-438F-93AE-025664AE9343Q47591072-85E3ED59-4E6B-413E-9FC1-30005CFE815CQ47950425-0E030BBC-CF47-4597-8A8C-DD35775A5849Q50610589-6AC16CA6-BF9F-42D7-B9A6-6FA42F4B537FQ50644972-FCD0F814-4045-4DC0-8F00-D3889C2799FAQ52012305-ADFF445D-A5B5-4675-B4FC-66481A556D50Q52655801-AEFF3F50-908B-45D7-AE68-4BE40C7C46B8Q53402458-D0A34E72-D380-4955-90F8-E4AEE71522D3Q54298658-1135CE54-1DEC-4E3E-A818-816A20162508Q56334606-7EAAB021-B74A-44C9-B085-AEB891130E01Q58848774-1E382274-7985-4000-A581-3CC4A04A1DFA
P2860
American tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
American tegumentary leishmani ...... epidemiologic characteristics.
@ast
American tegumentary leishmani ...... epidemiologic characteristics.
@en
type
label
American tegumentary leishmani ...... epidemiologic characteristics.
@ast
American tegumentary leishmani ...... epidemiologic characteristics.
@en
prefLabel
American tegumentary leishmani ...... epidemiologic characteristics.
@ast
American tegumentary leishmani ...... epidemiologic characteristics.
@en
P2093
P2860
P1476
American tegumentary leishmani ...... epidemiologic characteristics.
@en
P2093
Da-Cruz AM
Fernandes O
Gonçalves-Costa SC
Menezes CR
de Oliveira-Neto MP
P2860
P304
P356
10.1046/J.1365-4362.2000.00969.X
P577
2000-07-01T00:00:00Z